logo

For the Inventor, By the Inventor

Halle, Germany

Stefan Fankhänel

This inventor holds 3 USPTO granted patents. Top assignee: Novosom Ag. Active years: 2007-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Fankhänel. Retrieved from https://idiyas.com/inventor/stefan-fankhänel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 4.3

ph-index = 3

Forward Citations = 129(Granted Patents)


Location History:

  • Halle, DE (2007 - 2008)
  • Borsdorf, DE (2010)

Company Filing History:

goldMedal3 out of 8 
 
Novosom Ag
 patents

Years Active: 2007-2010

Loading Chart...
3 patents (USPTO):Explore Patents
1. 7780983 - Amphoteric liposomes (2010-08-24),
2. 7371404 - Amphoteric liposomes and their use (2008-05-13),
3. 7312206 - Sterol derivatives, liposomes comprising sterol derivatives and method for loading liposomes with active substances (2007-12-25),

Title: Innovations of Inventor Stefan Fankhänel

Introduction

Stefan Fankhänel is a notable inventor based in Halle, Germany. He has made significant contributions to the field of liposome technology, with a focus on amphoteric liposomes. His innovative work has led to the development of several patents that enhance the understanding and application of these unique structures.

Latest Patents

Stefan Fankhänel holds 3 patents related to amphoteric liposomes. His latest patents include the proposal of amphoteric liposomes that comprise both positive and negative membrane-based or membrane-forming charge carriers. These patents detail the use of these liposomes in various applications, showcasing their potential in advancing pharmaceutical and biotechnological fields.

Career Highlights

Stefan Fankhänel is associated with Novosom AG, a company that specializes in innovative drug delivery systems. His work at Novosom AG has allowed him to explore the practical applications of his inventions, contributing to the company's mission of developing advanced therapeutic solutions.

Collaborations

Throughout his career, Stefan has collaborated with notable colleagues, including Steffen Panzner and Frank Essler. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Stefan Fankhänel's contributions to the field of amphoteric liposomes highlight his innovative spirit and dedication to advancing scientific knowledge. His patents and work at Novosom AG continue to influence the landscape of drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…